Treatment of Neuroterrorism
Abstract Bioterrorism is defined as the intentional use of biological, chemical, nuclear, or radiological agents to cause disease, death, or environmental damage. Early recognition of a bioterrorist attack is of utmost importance to minimize casualties and initiate appropriate therapy. The range of...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Busl, Katharina M. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2012 |
|---|
| Schlagwörter: |
|---|
| Anmerkung: |
© The American Society for Experimental NeuroTherapeutics, Inc. 2012 |
|---|
| Übergeordnetes Werk: |
Enthalten in: NeuroRX - Springer-Verlag, 2006, 9(2012), 1 vom: Jan., Seite 139-157 |
|---|---|
| Übergeordnetes Werk: |
volume:9 ; year:2012 ; number:1 ; month:01 ; pages:139-157 |
| Links: |
|---|
| DOI / URN: |
10.1007/s13311-011-0097-2 |
|---|
| Katalog-ID: |
SPR031267025 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR031267025 | ||
| 003 | DE-627 | ||
| 005 | 20230519175149.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201007s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s13311-011-0097-2 |2 doi | |
| 035 | |a (DE-627)SPR031267025 | ||
| 035 | |a (SPR)s13311-011-0097-2-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Busl, Katharina M. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatment of Neuroterrorism |
| 264 | 1 | |c 2012 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The American Society for Experimental NeuroTherapeutics, Inc. 2012 | ||
| 520 | |a Abstract Bioterrorism is defined as the intentional use of biological, chemical, nuclear, or radiological agents to cause disease, death, or environmental damage. Early recognition of a bioterrorist attack is of utmost importance to minimize casualties and initiate appropriate therapy. The range of agents that could potentially be used as weapons is wide, however, only a few of these agents have all the characteristics making them ideal for that purpose. Many of the chemical and biological weapons can cause neurological symptoms and damage the nervous system in varying degrees. Therefore, preparedness among neurologists is important. The main challenge is to be cognizant of the clinical syndromes and to be able to differentiate diseases caused by bioterrorism from naturally occurring disorders. This review provides an overview of the biological and chemical warfare agents, with a focus on neurological manifestation and an approach to treatment from a perspective of neurological critical care. | ||
| 650 | 4 | |a Neuroterrorism |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Bioterrorism |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Warfare Agents |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Bleck, Thomas P. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t NeuroRX |d Springer-Verlag, 2006 |g 9(2012), 1 vom: Jan., Seite 139-157 |w (DE-627)SPR031264964 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2012 |g number:1 |g month:01 |g pages:139-157 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s13311-011-0097-2 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2012 |e 1 |c 01 |h 139-157 | ||
| author_variant |
k m b km kmb t p b tp tpb |
|---|---|
| matchkey_str |
buslkatharinambleckthomasp:2012----:ramnonuoe |
| hierarchy_sort_str |
2012 |
| publishDate |
2012 |
| allfields |
10.1007/s13311-011-0097-2 doi (DE-627)SPR031267025 (SPR)s13311-011-0097-2-e DE-627 ger DE-627 rakwb eng Busl, Katharina M. verfasserin aut Treatment of Neuroterrorism 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The American Society for Experimental NeuroTherapeutics, Inc. 2012 Abstract Bioterrorism is defined as the intentional use of biological, chemical, nuclear, or radiological agents to cause disease, death, or environmental damage. Early recognition of a bioterrorist attack is of utmost importance to minimize casualties and initiate appropriate therapy. The range of agents that could potentially be used as weapons is wide, however, only a few of these agents have all the characteristics making them ideal for that purpose. Many of the chemical and biological weapons can cause neurological symptoms and damage the nervous system in varying degrees. Therefore, preparedness among neurologists is important. The main challenge is to be cognizant of the clinical syndromes and to be able to differentiate diseases caused by bioterrorism from naturally occurring disorders. This review provides an overview of the biological and chemical warfare agents, with a focus on neurological manifestation and an approach to treatment from a perspective of neurological critical care. Neuroterrorism (dpeaa)DE-He213 Bioterrorism (dpeaa)DE-He213 Warfare Agents (dpeaa)DE-He213 Bleck, Thomas P. aut Enthalten in NeuroRX Springer-Verlag, 2006 9(2012), 1 vom: Jan., Seite 139-157 (DE-627)SPR031264964 nnns volume:9 year:2012 number:1 month:01 pages:139-157 https://dx.doi.org/10.1007/s13311-011-0097-2 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 9 2012 1 01 139-157 |
| spelling |
10.1007/s13311-011-0097-2 doi (DE-627)SPR031267025 (SPR)s13311-011-0097-2-e DE-627 ger DE-627 rakwb eng Busl, Katharina M. verfasserin aut Treatment of Neuroterrorism 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The American Society for Experimental NeuroTherapeutics, Inc. 2012 Abstract Bioterrorism is defined as the intentional use of biological, chemical, nuclear, or radiological agents to cause disease, death, or environmental damage. Early recognition of a bioterrorist attack is of utmost importance to minimize casualties and initiate appropriate therapy. The range of agents that could potentially be used as weapons is wide, however, only a few of these agents have all the characteristics making them ideal for that purpose. Many of the chemical and biological weapons can cause neurological symptoms and damage the nervous system in varying degrees. Therefore, preparedness among neurologists is important. The main challenge is to be cognizant of the clinical syndromes and to be able to differentiate diseases caused by bioterrorism from naturally occurring disorders. This review provides an overview of the biological and chemical warfare agents, with a focus on neurological manifestation and an approach to treatment from a perspective of neurological critical care. Neuroterrorism (dpeaa)DE-He213 Bioterrorism (dpeaa)DE-He213 Warfare Agents (dpeaa)DE-He213 Bleck, Thomas P. aut Enthalten in NeuroRX Springer-Verlag, 2006 9(2012), 1 vom: Jan., Seite 139-157 (DE-627)SPR031264964 nnns volume:9 year:2012 number:1 month:01 pages:139-157 https://dx.doi.org/10.1007/s13311-011-0097-2 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 9 2012 1 01 139-157 |
| allfields_unstemmed |
10.1007/s13311-011-0097-2 doi (DE-627)SPR031267025 (SPR)s13311-011-0097-2-e DE-627 ger DE-627 rakwb eng Busl, Katharina M. verfasserin aut Treatment of Neuroterrorism 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The American Society for Experimental NeuroTherapeutics, Inc. 2012 Abstract Bioterrorism is defined as the intentional use of biological, chemical, nuclear, or radiological agents to cause disease, death, or environmental damage. Early recognition of a bioterrorist attack is of utmost importance to minimize casualties and initiate appropriate therapy. The range of agents that could potentially be used as weapons is wide, however, only a few of these agents have all the characteristics making them ideal for that purpose. Many of the chemical and biological weapons can cause neurological symptoms and damage the nervous system in varying degrees. Therefore, preparedness among neurologists is important. The main challenge is to be cognizant of the clinical syndromes and to be able to differentiate diseases caused by bioterrorism from naturally occurring disorders. This review provides an overview of the biological and chemical warfare agents, with a focus on neurological manifestation and an approach to treatment from a perspective of neurological critical care. Neuroterrorism (dpeaa)DE-He213 Bioterrorism (dpeaa)DE-He213 Warfare Agents (dpeaa)DE-He213 Bleck, Thomas P. aut Enthalten in NeuroRX Springer-Verlag, 2006 9(2012), 1 vom: Jan., Seite 139-157 (DE-627)SPR031264964 nnns volume:9 year:2012 number:1 month:01 pages:139-157 https://dx.doi.org/10.1007/s13311-011-0097-2 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 9 2012 1 01 139-157 |
| allfieldsGer |
10.1007/s13311-011-0097-2 doi (DE-627)SPR031267025 (SPR)s13311-011-0097-2-e DE-627 ger DE-627 rakwb eng Busl, Katharina M. verfasserin aut Treatment of Neuroterrorism 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The American Society for Experimental NeuroTherapeutics, Inc. 2012 Abstract Bioterrorism is defined as the intentional use of biological, chemical, nuclear, or radiological agents to cause disease, death, or environmental damage. Early recognition of a bioterrorist attack is of utmost importance to minimize casualties and initiate appropriate therapy. The range of agents that could potentially be used as weapons is wide, however, only a few of these agents have all the characteristics making them ideal for that purpose. Many of the chemical and biological weapons can cause neurological symptoms and damage the nervous system in varying degrees. Therefore, preparedness among neurologists is important. The main challenge is to be cognizant of the clinical syndromes and to be able to differentiate diseases caused by bioterrorism from naturally occurring disorders. This review provides an overview of the biological and chemical warfare agents, with a focus on neurological manifestation and an approach to treatment from a perspective of neurological critical care. Neuroterrorism (dpeaa)DE-He213 Bioterrorism (dpeaa)DE-He213 Warfare Agents (dpeaa)DE-He213 Bleck, Thomas P. aut Enthalten in NeuroRX Springer-Verlag, 2006 9(2012), 1 vom: Jan., Seite 139-157 (DE-627)SPR031264964 nnns volume:9 year:2012 number:1 month:01 pages:139-157 https://dx.doi.org/10.1007/s13311-011-0097-2 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 9 2012 1 01 139-157 |
| allfieldsSound |
10.1007/s13311-011-0097-2 doi (DE-627)SPR031267025 (SPR)s13311-011-0097-2-e DE-627 ger DE-627 rakwb eng Busl, Katharina M. verfasserin aut Treatment of Neuroterrorism 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The American Society for Experimental NeuroTherapeutics, Inc. 2012 Abstract Bioterrorism is defined as the intentional use of biological, chemical, nuclear, or radiological agents to cause disease, death, or environmental damage. Early recognition of a bioterrorist attack is of utmost importance to minimize casualties and initiate appropriate therapy. The range of agents that could potentially be used as weapons is wide, however, only a few of these agents have all the characteristics making them ideal for that purpose. Many of the chemical and biological weapons can cause neurological symptoms and damage the nervous system in varying degrees. Therefore, preparedness among neurologists is important. The main challenge is to be cognizant of the clinical syndromes and to be able to differentiate diseases caused by bioterrorism from naturally occurring disorders. This review provides an overview of the biological and chemical warfare agents, with a focus on neurological manifestation and an approach to treatment from a perspective of neurological critical care. Neuroterrorism (dpeaa)DE-He213 Bioterrorism (dpeaa)DE-He213 Warfare Agents (dpeaa)DE-He213 Bleck, Thomas P. aut Enthalten in NeuroRX Springer-Verlag, 2006 9(2012), 1 vom: Jan., Seite 139-157 (DE-627)SPR031264964 nnns volume:9 year:2012 number:1 month:01 pages:139-157 https://dx.doi.org/10.1007/s13311-011-0097-2 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 9 2012 1 01 139-157 |
| language |
English |
| source |
Enthalten in NeuroRX 9(2012), 1 vom: Jan., Seite 139-157 volume:9 year:2012 number:1 month:01 pages:139-157 |
| sourceStr |
Enthalten in NeuroRX 9(2012), 1 vom: Jan., Seite 139-157 volume:9 year:2012 number:1 month:01 pages:139-157 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Neuroterrorism Bioterrorism Warfare Agents |
| isfreeaccess_bool |
false |
| container_title |
NeuroRX |
| authorswithroles_txt_mv |
Busl, Katharina M. @@aut@@ Bleck, Thomas P. @@aut@@ |
| publishDateDaySort_date |
2012-01-01T00:00:00Z |
| hierarchy_top_id |
SPR031264964 |
| id |
SPR031267025 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR031267025</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519175149.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2012 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s13311-011-0097-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR031267025</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s13311-011-0097-2-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Busl, Katharina M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment of Neuroterrorism</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2012</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© The American Society for Experimental NeuroTherapeutics, Inc. 2012</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Bioterrorism is defined as the intentional use of biological, chemical, nuclear, or radiological agents to cause disease, death, or environmental damage. Early recognition of a bioterrorist attack is of utmost importance to minimize casualties and initiate appropriate therapy. The range of agents that could potentially be used as weapons is wide, however, only a few of these agents have all the characteristics making them ideal for that purpose. Many of the chemical and biological weapons can cause neurological symptoms and damage the nervous system in varying degrees. Therefore, preparedness among neurologists is important. The main challenge is to be cognizant of the clinical syndromes and to be able to differentiate diseases caused by bioterrorism from naturally occurring disorders. This review provides an overview of the biological and chemical warfare agents, with a focus on neurological manifestation and an approach to treatment from a perspective of neurological critical care.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neuroterrorism</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bioterrorism</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Warfare Agents</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bleck, Thomas P.</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">NeuroRX</subfield><subfield code="d">Springer-Verlag, 2006</subfield><subfield code="g">9(2012), 1 vom: Jan., Seite 139-157</subfield><subfield code="w">(DE-627)SPR031264964</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:9</subfield><subfield code="g">year:2012</subfield><subfield code="g">number:1</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:139-157</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s13311-011-0097-2</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">9</subfield><subfield code="j">2012</subfield><subfield code="e">1</subfield><subfield code="c">01</subfield><subfield code="h">139-157</subfield></datafield></record></collection>
|
| author |
Busl, Katharina M. |
| spellingShingle |
Busl, Katharina M. misc Neuroterrorism misc Bioterrorism misc Warfare Agents Treatment of Neuroterrorism |
| authorStr |
Busl, Katharina M. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)SPR031264964 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
Treatment of Neuroterrorism Neuroterrorism (dpeaa)DE-He213 Bioterrorism (dpeaa)DE-He213 Warfare Agents (dpeaa)DE-He213 |
| topic |
misc Neuroterrorism misc Bioterrorism misc Warfare Agents |
| topic_unstemmed |
misc Neuroterrorism misc Bioterrorism misc Warfare Agents |
| topic_browse |
misc Neuroterrorism misc Bioterrorism misc Warfare Agents |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
NeuroRX |
| hierarchy_parent_id |
SPR031264964 |
| hierarchy_top_title |
NeuroRX |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)SPR031264964 |
| title |
Treatment of Neuroterrorism |
| ctrlnum |
(DE-627)SPR031267025 (SPR)s13311-011-0097-2-e |
| title_full |
Treatment of Neuroterrorism |
| author_sort |
Busl, Katharina M. |
| journal |
NeuroRX |
| journalStr |
NeuroRX |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2012 |
| contenttype_str_mv |
txt |
| container_start_page |
139 |
| author_browse |
Busl, Katharina M. Bleck, Thomas P. |
| container_volume |
9 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Busl, Katharina M. |
| doi_str_mv |
10.1007/s13311-011-0097-2 |
| title_sort |
treatment of neuroterrorism |
| title_auth |
Treatment of Neuroterrorism |
| abstract |
Abstract Bioterrorism is defined as the intentional use of biological, chemical, nuclear, or radiological agents to cause disease, death, or environmental damage. Early recognition of a bioterrorist attack is of utmost importance to minimize casualties and initiate appropriate therapy. The range of agents that could potentially be used as weapons is wide, however, only a few of these agents have all the characteristics making them ideal for that purpose. Many of the chemical and biological weapons can cause neurological symptoms and damage the nervous system in varying degrees. Therefore, preparedness among neurologists is important. The main challenge is to be cognizant of the clinical syndromes and to be able to differentiate diseases caused by bioterrorism from naturally occurring disorders. This review provides an overview of the biological and chemical warfare agents, with a focus on neurological manifestation and an approach to treatment from a perspective of neurological critical care. © The American Society for Experimental NeuroTherapeutics, Inc. 2012 |
| abstractGer |
Abstract Bioterrorism is defined as the intentional use of biological, chemical, nuclear, or radiological agents to cause disease, death, or environmental damage. Early recognition of a bioterrorist attack is of utmost importance to minimize casualties and initiate appropriate therapy. The range of agents that could potentially be used as weapons is wide, however, only a few of these agents have all the characteristics making them ideal for that purpose. Many of the chemical and biological weapons can cause neurological symptoms and damage the nervous system in varying degrees. Therefore, preparedness among neurologists is important. The main challenge is to be cognizant of the clinical syndromes and to be able to differentiate diseases caused by bioterrorism from naturally occurring disorders. This review provides an overview of the biological and chemical warfare agents, with a focus on neurological manifestation and an approach to treatment from a perspective of neurological critical care. © The American Society for Experimental NeuroTherapeutics, Inc. 2012 |
| abstract_unstemmed |
Abstract Bioterrorism is defined as the intentional use of biological, chemical, nuclear, or radiological agents to cause disease, death, or environmental damage. Early recognition of a bioterrorist attack is of utmost importance to minimize casualties and initiate appropriate therapy. The range of agents that could potentially be used as weapons is wide, however, only a few of these agents have all the characteristics making them ideal for that purpose. Many of the chemical and biological weapons can cause neurological symptoms and damage the nervous system in varying degrees. Therefore, preparedness among neurologists is important. The main challenge is to be cognizant of the clinical syndromes and to be able to differentiate diseases caused by bioterrorism from naturally occurring disorders. This review provides an overview of the biological and chemical warfare agents, with a focus on neurological manifestation and an approach to treatment from a perspective of neurological critical care. © The American Society for Experimental NeuroTherapeutics, Inc. 2012 |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA |
| container_issue |
1 |
| title_short |
Treatment of Neuroterrorism |
| url |
https://dx.doi.org/10.1007/s13311-011-0097-2 |
| remote_bool |
true |
| author2 |
Bleck, Thomas P. |
| author2Str |
Bleck, Thomas P. |
| ppnlink |
SPR031264964 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s13311-011-0097-2 |
| up_date |
2024-07-03T22:56:46.344Z |
| _version_ |
1803600429166100480 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR031267025</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519175149.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2012 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s13311-011-0097-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR031267025</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s13311-011-0097-2-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Busl, Katharina M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment of Neuroterrorism</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2012</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© The American Society for Experimental NeuroTherapeutics, Inc. 2012</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Bioterrorism is defined as the intentional use of biological, chemical, nuclear, or radiological agents to cause disease, death, or environmental damage. Early recognition of a bioterrorist attack is of utmost importance to minimize casualties and initiate appropriate therapy. The range of agents that could potentially be used as weapons is wide, however, only a few of these agents have all the characteristics making them ideal for that purpose. Many of the chemical and biological weapons can cause neurological symptoms and damage the nervous system in varying degrees. Therefore, preparedness among neurologists is important. The main challenge is to be cognizant of the clinical syndromes and to be able to differentiate diseases caused by bioterrorism from naturally occurring disorders. This review provides an overview of the biological and chemical warfare agents, with a focus on neurological manifestation and an approach to treatment from a perspective of neurological critical care.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neuroterrorism</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bioterrorism</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Warfare Agents</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bleck, Thomas P.</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">NeuroRX</subfield><subfield code="d">Springer-Verlag, 2006</subfield><subfield code="g">9(2012), 1 vom: Jan., Seite 139-157</subfield><subfield code="w">(DE-627)SPR031264964</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:9</subfield><subfield code="g">year:2012</subfield><subfield code="g">number:1</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:139-157</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s13311-011-0097-2</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">9</subfield><subfield code="j">2012</subfield><subfield code="e">1</subfield><subfield code="c">01</subfield><subfield code="h">139-157</subfield></datafield></record></collection>
|
| score |
7.4018335 |